Enhancement of solubility and dissolution rate of meloxicam by solid dispersions in superdisintegrants

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 1, Issue 4, 2010, Pages 655-671

  Niharika, A ^a   Sundaramoorthy, K ^a   Vetrichelvan, T ^a  

^a ADHIPARASAKTHI COLLEGE OF PHARMACY   (India)

Author keywords

Dissolution; Meloxicam; Solid dispersion; Solubility

Indexed keywords

CELLULOSE; CROSCARMELLOSE SODIUM; CROSPOVIDONE; DISINTEGRATING AGENT; MELOXICAM; MICROCRYSTALLINE CELLULOSE;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG ANALYSIS; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG MIXTURE; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; EVAPORATION; HYDROPHILICITY; INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SOLVENT EFFECT; WETTABILITY; X RAY DIFFRACTION;

EID: 79952505689     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. st edn. Vallabh Pakistan, New Delhi, 2005, 5, 20-25.
2. Dhirendra K, Lewis S, Udupa N, Atink. Pakisthan J Pharm Sci 2009; 22(2): 234-235.
3. Kavin C G, Anil J S, Namdeo R J, Harinath N M. Pharm Dev Technol 2007; 6(7):43-49.
4. th edn. Mac Millan Publishing Company, New York, 2001, 671-711.
5. Babu P S, and Chowdary K P R. Indian Drugs 2008; 45(7): 547-552.
6. Narendra K, Akhilesh K J, Chater S. Asian J Pharm Sci 2005, 29, 154-158.
7. Patel DM, Shah RR, and Jogani PD. Indian J Pharm Sci 2003; 65(3): 264-267.
8. United States Pharmacopoeia. XXVII, NF XXII. The United States pharmacopoeial convention Inc; 2002, 2870, 2875.
9. British Pharmacopoeia. London: Controller of her majesty's stationary office; 2002. Vol. I, 1249-125.
10. Malleswara Rao VSN, Shyam T, Appa RB, and Srinivas RY. Int J Pharm Excipient 2007; 43-38.
11. Mahaparale PR, Gudsoorkar VR, Gajeli GB, and Kuchekar BS. Indian J Pharm Edu Res 2006;43(4): 241-245.
12. Mahmoud EB, Gihan F and Mohamed F. South Pharm J 2009; 17(3): 219-228.
13. Sengodan G.V.K, and Dinanath M. The Pharm Soc Japan 2005; 126(2): 93-97.
14. Robert JT and Nicholas GL. Drug Dev Ind Pharm 1984; 10(3): 425-451.
15. Mohamed HGD and Mohamed J. Iranian J Pharm Res 2006; 4: 231-238.
16. nd edn., Vignesh publications, Chennai, 2004, 295-298.
17. Sanoferjan AM, Nanjundaswamy NG, Mahesh S and Narasimha MS. Indian J Pharm Sci 2000; 62(2): 119-121.